European Huntington's Disease Network (EHDN) Clinical Research Congress 2026 in Kraków

Advancing Huntington’s disease research | EHDN 2026

It was great to be part of the European Huntington's Disease Network (EHDN) Clinical Research Congress 2026 in Kraków, bringing together the Huntington’s disease research community to share scientific advances, clinical developments and emerging therapeutic approaches.

Representing Harness Therapeutics, Madeleine Wakeling and Laura Heraty joined discussions on the latest research and progress towards new treatments for Huntington’s disease.

Thank you to the organisers and everyone involved for an insightful event.

#EHDN2026 #HuntingtonsDisease #Neuroscience

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Parkinson’s Disease

Discover more

Our news

June 2026

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson's Disease Programme

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

View all